Zetta Genomics
Private Company
Total funding raised: $3.5M
Overview
Zetta Genomics is a private, revenue-generating bioinformatics platform company focused on solving the data management and analysis bottleneck in genomic medicine. Its core product, XetaBase, is a genomic-native variant store built on open-source technology (OpenCB) that aggregates and indexes hundreds of thousands of genomes to enable rapid, scalable querying and re-interpretation. The company targets healthcare systems, life sciences firms, and research institutions, positioning itself as an essential infrastructure player to enable precision medicine at population scale. Its deep academic roots and proven deployment in large-scale projects provide a strong foundation for growth in the expanding genomic data market.
Technology Platform
XetaBase: A cloud-native, genomic variant store and analysis platform built on the open-source OpenCB stack. It aggregates and indexes hundreds of thousands of genomes for rapid querying, visualization, and re-interpretation in research and clinical settings.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Competes in the genomic data platform market against large cloud hyperscalers (AWS, Google, Microsoft), specialized bioinformatics SaaS companies (e.g., DNAnexus), and legacy informatics tools. Differentiation is based on its genomic-native architecture, proven scalability from the 100,000 Genomes Project, and dual research/clinical functionality.